Nucleosome ELISA (NU-ELISA) is a sensitive and quantitative method to detect global patterns of post-translational modifications in preparations of native, intact nucleosomes. These modifications include methylations, acetylations, and phosphorylations at specific histone amino acid residues, and hence NU-ELISA provides a global proteomic assay of the overall chromatin modification states of specific cell types.
The genome of eukaryotes exists as chromatin which contains both DNA and proteins. The fundamental unit of chromatin is the nucleosome, which contains 146 base pairs of DNA associated with two each of histones H2A, H2B, H3, and H41. The N-terminal tails of histones are rich in lysine and arginine and are modified post-transcriptionally by acetylation, methylation, and other post-translational modifications (PTMs). The PTM configuration of nucleosomes can affect the transcriptional activity of associated DNA, thus providing a mode of gene regulation that is epigenetic in nature 2,3. We developed a method called nucleosome ELISA (NU-ELISA) to quantitatively determine global PTM signatures of nucleosomes extracted from cells. NU-ELISA is more sensitive and quantitative than western blotting, and is useful to interrogate the epiproteomic state of specific cell types. This video journal article shows detailed procedures to perform NU-ELISA analysis.
1. Mammalian Cell Culture
NU-ELISA can be performed on any mammalian cell type that can be grown in culture. We prefer to prepare moderate to large batches of cells so that nucleosomes can be isolated in sufficient quantity to prepare several identically loaded ELISA plates, thus allowing assays with several different antibodies (Abs). The following culture scales provide ample material:
For mouse embyronic stem cells, grow one or two 15 cm plates of cells without feeder cells. For fibroblasts, grow 5 to 10 15 cm plates to confluence.
2. Isolation of Nuclei
Note: All the steps are on ice with pre-chilled buffers, except as indicated.
3. Isolation of Nucleosomes by in situ Micrococcal Nuclease (MNase) Digestion
We use a procedure in which chromatin is digested in situ within nuclei by infusing them with MNase, followed by a hypotonic treatment to drive free intact nucleosomes into the supernatant.
Note: The amount of chromatin can be crudely quantitated by measuring absorbance at 260 nm of a 10 μl sample added to 990 μl of water. A260=10 (after adjusting for the 1/100 dilution) corresponds to about 1mg/ml of chromatin. Also, during the above procedure, small samples may be retained and later analyzed for their DNA content to monitor the quality and extent of MNase digestions, which should predominantly contain DNA of 146 bp in length. Laddering is indicative of incomplete MNase digestion.
Note: Fig.1 contains a diagrammed summary of nuclear isolation and MNase digestions steps.
4. Nucleosome-ELISA (NU-ELISA)
We detect PTMs on fractions containing native intact nuclesosomes that have been immobilized on 96 well ELISA microtiter plates. For each sample, we make a series of 2-fold dilutions, and these are coated onto wells in triplicate.
Reagents
PBS/butyrate |
135 mM NaCl |
2.5 mM KCl |
8 mM Na2HPO4 |
1.5 mM KH2PO4 |
10 mM Na-butyrate |
Lysis Buffer |
250 mM sucrose |
10 mM Tris-HCl, pH 7.4 |
10 mM Na-butyrate |
4 mM MgCl2 |
0.1% Triton X-100 |
Wash buffer C |
250 mM sucrose |
10 mM Tris-HCl, pH 7.4 |
10 mM Na-butyrate |
4 mM MgCl2 |
Sucrose Cushion |
30% (w/v) sucrose in wash buffer C |
Microccocal Nuclease Buffer |
5 mM NaPO4 Buffer, pH 7.0 |
0.025 mM CaCl2 |
Coating buffer |
80ml Solution A + 170ml Solution B + 250ml dH2O |
Solution A: 0.2 M Na2CO3 |
Solution B: 0.2 M NaHCO3 |
5. Representative Results
Using the NU-ELISA method, a series of several identical plates are prepared which can be loaded with chromatin prepared in the form of mononucleosomes. We typically prepare series of identically-loaded plates so that each can be probed with different anti-PTM specific antibodies (Abs). We also always prepare a plate that can be probed with an Ab that detects histones without regard to their modification state total chromatin loading control. This control is essential in order to later quantitatively compare PTM content of nucleosomes prepared from different samples. To quantitate the levels of PTMs within a given chromatin sample we correct the raw absorbance values using this approach: First, we subtract any background signal using values obtained from control wells containing no chromatin (background is usually negligible). We then standardize PTM-specific signals to NU-ELISA results obtained from an identically loaded plate that was assayed with an Ab that detects nucleosomes independent of their modification state. (We have used polyclonal Abs specific for histones H2A or H2B for this purpose). We then determine means and variances for each dilution of chromatin, and use data obtained from the linear portion of the ELISA assay. Detailed examples of NU-ELISA mathematical and statistical analyses have been reported previously4
Figure 1. Schematic diagam of NU-ELISA steps. A. Mammalian Cells are harvested; B. Nuclei are separated from cells by Dounce homogenization, C. Disrupted cells are loaded on top of a 30% w/v sucrose cushion, D. After centrifugation, nuclei are deposited in the pellet; E, F. Chromatin are digested in situ to predominantly mononucleomes by MNase; G, H, I. Soluble mononucleosomes are extracted by hypotonic treatment and repeated centrifugation of residual nuclear material. J. Mononucleosomes from different samples (labeled samp. 1 and 2 in this case) are coated on microtiter wells in series of identically-loaded plates and interrogated with PTM-specific Abs and PTM-independent Abs to determine total chromatin loading. K. Depiction of differential signal detection levels in two samples that differ in their PTM content, yet have similar overall chromatin content, as judged by anti-H2B immunoreactivity.
NU-ELISA provides a method to ascertain the global status of nucleosome PTMs present within a particular cell type. NU-ELISA studies have shown that global nucleosome modification states differ in comparisons of divergent cell types 4. In addition, NU-ELISA PTM profiles change when cells are exposed to epigenetic modulatory agents such as trichostatin-A or when mouse embyronic stem cells are differentiated 4. The method has also been applied successfully to study the chromatin of human ES cells5. It is important to note the NU-ELISA, in its present form, can detect only the composite signature of PTMs present within the sum total of the cellular epigenome. This differs markedly from genome-wide chromatin immunoprecipitation, which can determine the distribution of a specific PTM across specific genetic loci.
The initial steps of the NU-ELISA procedures are adapted from previous methods to isolate mononucleosomes from mammalian nuclei6,7. These adapted methods provide an expedient way to obtain high-quality intact mononucleosomes from mammalian cells, and the resulting fractions are comprehensive in their chromatin content, but contain a great deal of additional nuclear material. Since specific Abs are used, contaminating non-nucleosomal material is tolerated well in the NU-ELISA assay, unlike mass-spec approaches that require greater purity. However, NU-ELISA is more sensitive and quantitative than western blotting 4, thus providing good alternatives to westerns and mass spec for the detection of nucleosomal PTMs.
The authors have nothing to disclose.
Development of the NU-ELISA method was supported by NIH grant RO1AG023687.
Name of the reagent | Company | Catalogue number | コメント |
---|---|---|---|
Micrococcal Nucleae | Sigma | N3755 | Make aliquots of 2 U/10μl buffer, stored at -20°C |
Nunc MaxiSorp Microtiter Plates | Fisher | 12-565-135 | Adhesive plate covers can also be ordered through Fisher |
Automated Plate Washer | |||
1-Step TMB-ELISA substrate | Pierce | 34028 | Store at 4°C pre-warm to RT before use or as directed on the specification sheet |
Microtiter Plate Reader | Bio-Rad microplate reader (model: 680) | Most colorimetric plate reader models are suitable |